Confirming microarray data - Is it really necessary?

Genomics

Volumn 83, Issue 4, 2004, Pages 541-549

  Rockett, John C ^a   Hellmann, Gary M ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS HYBRIDIZATION; DNA MICROARRAY; EXPERIMENTATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; METHODOLOGY; MOLECULAR CLONING; NONHUMAN; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA SPLICING; SCIENTIFIC LITERATURE; STANDARD;

EID: 1542613788     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygeno.2003.09.017     Document Type: Article

References (42)

1. Fodor S.P., Rava R.P., Huang X.C., Pease A.C., Holmes C.P., Adams C.L. Multiplexed biochemical assays with biological chips. Nature. 364:1993;555-556.
2. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
3. Saiki R.K.et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1985;1350-1354.
4. Rota P.A.et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:2003;1394-1399.
5. Golub T.R.et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286:1999;531-537.
6. Burczynski M.E.et al. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58:2000;399-415.
7. Hamadeh H.K.et al. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67:2002;219-231.
8. Thomas R.S.et al. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60:2001;1189-1194.
9. Stratowa C.et al. cDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int. J. Cancer. 91:2001;474-480.
10. Tang Y., Lu A., Aronow B.J., Sharp F.R. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann. Neurol. 50:2001;699-707.
11. Kier L., Nolan T. Gene expression biomarkers that accurately predict kidney tubular necrosis. Toxicol. Sci. 72(S-1):2003;151.
12. Kaneta Y.et al. Prediction of sensitivity to STI571 among chronic myeloid leukemia patients by genome-wide cDNA microarray analysis. Jpn. J. Cancer Res. 93:2002;849-856.
13. Huang E.et al. Gene expression predictors of breast cancer outcomes. Lancet. 361:2003;1590-1596.
14. Kannan K., Kaminski N., Rechavi G., Jakob-Hirsch J., Amariglio N., Givol D. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene. 20:2001;3449-3455.
15. Brazma A., Robinson A., Cameron G., Ashburner M. One-stop shop for microarray data. Nature. 403:2000;699-700.
16. MGED, Microarray Gene Expression Data Society - MGED Society, accessed September 10, 2003, at http://www.mged.org/.
17. MIAME-TOX, Minimum Information About a Microarray Experiment: MIAME for toxicogenomics (MIAME/Tox), accessed June 18, 2003, at http://216.239.39.100/ search?q = cache:cy23_6a5JNgJ: www.mged.org/ MIAME1.1-DenverDraft.DOC+MIAME- TOX&hl = en&ie = UTF-8.
18. GEO, Gene Expression Omnibus, accessed June 9, 2003, at http://www.ncbi.nlm.nih.gov/geo/.
19. ArrayExpress, accessed June 9, 2003, at http://www.ebi.ac.uk/microarray/ ArrayExpress/arrayexpress.html.
20. DDBJ, DNA Data Bank of Japan, accessed September 10, 2003, at http://www.ddbj.nig.ac.jp/.
21. EMBL, EMBL Nucleotide Sequence Database, accessed September 10, 2003, at http://www.ebi.ac.uk/embl/.
22. GenBank, accessed September 10, 2003, at http://www.ncbi.nlm.nih.gov/ Genbank/index.html.
23. EPA 2002 Interim Genomics Policy, accessed June 24, 2003, at http://epa.gov/osp/spc/genomics.htm.
24. G.E. Marchant, Genomics and environmental regulation: scenarios and implications, accessed June 24, 2003, at http://www.epa.gov/osp/presentations/ futures/marchant.pdf.
25. Robinson D.E., Petit S.D., Morgan D.G. Use of genomics in mechanism based risk assessment. Inoue T., Pennie W.D. Toxicogenomics. 2003;194-203 Springer-Verlag, Tokyo.
26. Modrek B., Lee C. A genomic view of alternative splicing. Nat. Genet. 30:2002;13-19.
27. Bartel F., Taubert H., Harris L.C. Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell. 2:2002;9-15.
28. Barrett J.C., Kawasaki E.S. Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression. Drug Discovery Today. 8:2003;134-141.
29. Halgren R.G., Fielden M.R., Fong C.J., Zacharewski T.R. Assessment of clone identity and sequence fidelity for 1189 IMAGE cDNA clones. Nucleic Acids Res. 29:2001;582-588.
30. Taylor E.et al. Sequence verification as quality-control step for production of cDNA microarrays. Biotechniques. 31:2001;62-65.
31. Knight J. When the chips are down. Nature. 410:2001;460-461.
32. Goodman N. Microarrays: hazardous to your science. Genome Technol. April. 2003;42-45.
33. Kuo W.P., Jenssen T.K., Butte A.J., Ohno-Machado L., Kohane I.S. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics. 18:2002;405-412.
34. Rockett J.C. To confirm or not to confirm (microarray data) - that, is the question. Drug Discovery Today. 8:2003;343.
35. Carlisle A.J.et al. Development of a prostate cDNA microarray and statistical gene expression analysis package. Mol. Carcinog. 28:2000;12-22.
36. Chuaqui R.F.et al. Post-analysis follow-up and validation of microarray experiments. Nat. Genet. 32:2002;509-514.
37. Circulation research: suitability criteria for manuscripts utilizing genomics array technology. Circ. Res. 89:2001;469.
38. Firestein G.S., Pisetsky D.S. DNA microarrays: boundless technology or bound by technology? Guidelines for studies using microarray technology. Arthritis Rheum. 46:2002;859-861.
39. Aoyagi K.et al. A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. Biochem. Biophys. Res. Commun. 300:2003;915-920.
40. Iscove N.N., Barbara M., Gu M., Gibson M., Modi C., Winegarden N. Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat. Biotechnol. 20:2002;940-943.
41. Applied Biosystems, accessed June 18, 2003, at http://events-na. appliedbiosystems.com/mk/get/0905_ALLGENE_LANDING?isource = From www.allgenes.com.
42. Waters M.et al. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. EHP Toxicogenomics. 111(1T):2003;15-28.